[Federal Register Volume 62, Number 215 (Thursday, November 6, 1997)]
[Notices]
[Pages 60095-60096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29360]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice

[[Page 60096]]

is hereby given of the following National Cancer Institute Special 
Emphasis Panel (SEP) meeting:

    Name of SEP: Preclinical Toxicology Studies of Chemopreventive 
Agenda.
    Date: November 14, 1997.
    Time: 9:00 a.m. to Adjournment.
    Place: Executive Plaza North, Conference Room J, 6130 Executive 
Boulevard, Bethesda, MD 20892.
    Contact Person: Lalita Palekar, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, 6130 Executive 
Boulevard, EPN, Room 622B, Bethesda, MD 20892-7405, Telephone: 301/
496-7575.
    Purpose/Agenda: To review, discuss and evaluate responses to a 
Request for Proposal.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. Proposals 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the applications, 
the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394; Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 30, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-29360 Filed 11-5-97; 8:45 am]
BILLING CODE 4140-01-M